120 related articles for article (PubMed ID: 8994528)
1. Gastrin levels in serum and bronchoalveolar lavage fluid of patients with lung cancer: comparison with patients with chronic obstructive pulmonary disease.
Dowlati A; Bury T; Corhay JL; Weber T; Lamproye A; Mendes P; Radermecker M
Thorax; 1996 Dec; 51(12):1270-2. PubMed ID: 8994528
[TBL] [Abstract][Full Text] [Related]
2. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
3. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic significance of gastrin measurement of bronchoalveolar lavage fluid for lung cancer.
Zhou Q; Yang Z; Yang J; Tian Z; Zhang H
J Surg Oncol; 1992 Jun; 50(2):121-4. PubMed ID: 1317485
[TBL] [Abstract][Full Text] [Related]
5. Soluble and cell-associated transferrin receptor in lung cancer.
Dowlati A; Loo M; Bury T; Fillet G; Beguin Y
Br J Cancer; 1997; 75(12):1802-6. PubMed ID: 9192985
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Dowlati A; Levitan N; Remick SC
J Lab Clin Med; 1999 Oct; 134(4):405-9. PubMed ID: 10521088
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
[TBL] [Abstract][Full Text] [Related]
9. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.
Bridgeman MM; Marsden M; Selby C; Morrison D; MacNee W
Thorax; 1994 Jul; 49(7):670-5. PubMed ID: 8066561
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects.
Fracchia A; Ubbiali A; El Bitar O; Pacetti M; Sommariva E; Arreghini M; Longhini E; Bonalumi GP
Oncology; 1999 Apr; 56(3):181-8. PubMed ID: 10202271
[TBL] [Abstract][Full Text] [Related]
11. Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL.
Georgiades G; Myrianthefs P; Venetsanou K; Kythreoti A; Kyroudi A; Kittas C; Baltopoulos G
Lung; 2003; 181(1):35-47. PubMed ID: 12879338
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
13. Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy.
Beinert T; Binder D; Oehm C; Ziemer S; Priem F; Stuschke M; Schweigert M; Siebert G; Mergenthaler HG; Schmid P; Fleischhacker M; Possinger K
J Cancer Res Clin Oncol; 2000 Jun; 126(6):352-6. PubMed ID: 10870646
[TBL] [Abstract][Full Text] [Related]
14. IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients.
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():136-45. PubMed ID: 9337532
[TBL] [Abstract][Full Text] [Related]
15. BAL neopterin : a novel marker for cell-mediated immunity in patients with pulmonary tuberculosis and lung cancer.
Mohamed KH; Mobasher AA; Yousef AR; Salah A; El-Naggar IZ; Ghoneim AH; Light RW
Chest; 2001 Mar; 119(3):776-80. PubMed ID: 11243956
[TBL] [Abstract][Full Text] [Related]
16. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial.
Bingula R; Filaire E; Molnar I; Delmas E; Berthon JY; Vasson MP; Bernalier-Donadille A; Filaire M
Respir Res; 2020 May; 21(1):129. PubMed ID: 32450847
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
19. Clara cell protein in serum and bronchoalveolar lavage.
Bernard A; Marchandise FX; Depelchin S; Lauwerys R; Sibille Y
Eur Respir J; 1992 Nov; 5(10):1231-8. PubMed ID: 1486970
[TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
